Pietro Andreoné
About
In The Last Decade
Pietro Andreoné
331 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Hepatology 7.7k
- Epidemiology 7.1k
- Surgery 1.3k
- Infectious Diseases 824
- Oncology 822
Countries citing papers authored by Pietro Andreoné
This map shows the geographic impact of Pietro Andreoné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Andreoné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Andreoné more than expected).
Fields of papers citing papers by Pietro Andreoné
This network shows the impact of papers produced by Pietro Andreoné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Andreoné. The network helps show where Pietro Andreoné may publish in the future.
Co-authorship network of co-authors of Pietro Andreoné
This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Andreoné. A scholar is included among the top collaborators of Pietro Andreoné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Andreoné. Pietro Andreoné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 9 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 10 | |
| 6 | 3 | |
| 7 | 17 | |
| 8 | 80 | |
| 9 | 47 | |
| 10 | 71 | |
| 11 | What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group. | 2 |
| 12 | 12 | |
| 13 | 6 | |
| 14 | 40 | |
| 15 | 17 | |
| 16 | 5 | |
| 17 | 23 | |
| 18 | 1 | |
| 19 | Genetic heterogeneity of hepatitis C virus (HCV) in clinical strains of HIV positive and HIV negative patients chronically infected with HCV genotype 3a. | 9 |
| 20 | Hepatitis C virus infection and lymphoproliferative disorders. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.